Table 2.
The formation rate (nmol min−1 mg−1 protein) of OH-celecoxib at 1 and 20 µm celecoxib concentration in human liver microsomes, as well as total spectral P450 (pmol mg−1 protein) and apoprotein content in arbitrary units. n = number of individual liver samples, data expressed as mean ± s.d., §P < 0.05 compared with 2C9 *1/ *1, #P < 0.01 compared with 2C9 *1/ *2.
| Formation rate of OH-celecoxib | |||||
|---|---|---|---|---|---|
| Genotype | n | 1 µm celecoxib | 20 µm celecoxib | Total P 450 | CYP2C9 apoprotein |
| CYP2C9*1/*1 | 14 | 0.033 ± 0.012 | 0.26 ± 0.089 | 399 ± 201 | 7.2 ± 4.6 |
| CYP2C9*1/*2 | 6 | 0.030 ± 0.015 | 0.24 ± 0.070 | 454 ± 99 | 6.9 ± 3.3 |
| CYP2C9*1/*3 | 8 | 0.0150 ± 0065§# | 0.15 ± 0.14§ | 255 ± 105 | 4.8 ± 2.5 |
| CYP2C9*2/*3 | 2 | 0.037; 0.016 | 0.30; 0.18 | 594 ± 71 | 6.3; 5.3 |
| CYP2C9*2/*2 | 4 | 0.021 ± 0.011 | 0.16 ± 0.12 | 515 ± 356 | 4.1 ± 0.7 |
| CYP2C9*3/*3 | 1 | 0.0061 | 0.079 | 516 | 3.1 |